Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
EEF1A1P11 is a processed pseudogene derived from the eukaryotic translation elongation factor 1 alpha 1 (EEF1A1) gene. Pseudogenes like EEF1A1P11 are genomic DNA sequences similar to conventional genes but are typically non-functional due to mutations or lack of necessary regulatory elements. EEF1A1P11 is listed as located on chromosome 1p21.3 and has been noted in bioinformatic and cancer genomic studies, but there is no evidence that it encodes a protein or has a direct biological function[4][2]. While some EEF1A1 pseudogenes have been observed in the context of various cancers and metabolic diseases, these associations are largely correlative, and EEF1A1P11 itself is not a recognized biological or drug target[4][2]. EEF1A1P11 should not be confused with the functional protein eukaryotic translation elongation factor 1 alpha 1 (EEF1A1), which is vital for protein synthesis and has well-described enzymatic activity and biological roles[1][3][5].
null (not a functional target)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Eukaryotic translation elongation factor 1 alpha 1 pseudogene 11 (EEF1A1P11).